DBVT

DBV Technologies to Report First Half 2021 Financial Results and Business Updates on August 2, 2021

DBV Technologies to Present at Upcoming Investor Conferences

DBV Technologies Announces Results of its 2021 Ordinary and Extraordinary General Meeting and the Appointment of Dr. Adora Ndu, Pharm.D., J.D., and Dr. Ravi Madduri Rao, M.D.

DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021

DBV Technologies Reports Q1 2021 Financial Results

Ordinary and Extraordinary General Meeting of May 19, 2021 to be Held in Closed Virtual Session Due to COVID-19 Pandemic

DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors